DexCom (DXCM)
(Delayed Data from NSDQ)
$134.00 USD
+3.55 (2.72%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $134.05 +0.05 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DXCM 134.00 +3.55(2.72%)
Will DXCM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DXCM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DXCM
DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
DXCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Investment Ideas feature highlights: Vertiv, Align Technology and DexCom
3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
Other News for DXCM
Top high growth investment ratio stocks from each sector - GS
3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
First Week of December 20th Options Trading For DexCom (DXCM)
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
RBC Capital Keeps Their Buy Rating on Dexcom (DXCM)